mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.

Published on May 15, 2021in International Journal of Pharmaceutics5.875
路 DOI :10.1016/J.IJPHARM.2021.120586
Linde Schoenmaker1
Estimated H-index: 1
(LEI: Leiden University),
Dominik Witzigmann20
Estimated H-index: 20
(UBC: University of British Columbia)
+ 4 AuthorsDaan J.A. Crommelin90
Estimated H-index: 90
(UU: Utrecht University)
Abstract A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be stored at (ultra)low temperatures. Understanding the root cause of the instability of these vaccines may help to rationally improve mRNA-LNP product stability and thereby ease the temperature conditions for storage. In this review we discuss proposed structures of mRNA-LNPs, factors that impact mRNA-LNP stability and strategies to optimize mRNA-LNP product stability. Analysis of mRNA-LNP structures reveals that mRNA, the ionizable cationic lipid and water are present in the LNP core. The neutral helper lipids are mainly positioned in the outer, encapsulating, wall. mRNA hydrolysis is the determining factor for mRNA-LNP instability. It is currently unknown whether water in the LNP core can interact with the mRNA and to what extent the degradation prone sites of mRNA are protected through a coat of ionizable cationic lipids. To improve the stability of mRNA-LNP vaccines, optimization of the mRNA nucleotide composition should be prioritized. Secondly, a better understanding of the milieu the mRNA is exposed to in the core of LNPs may help to rationalize adjustments to the LNP structure to preserve mRNA integrity. Moreover, drying techniques, such as lyophilization, are promising options still to be explored.
馃摉 Papers frequently viewed together
12 Authors (Hiroki Tanaka, ..., Hidetaka Akita)
#1Rein Verbeke (UGent: Ghent University)H-Index: 8
#2Ine Lentacker (UGent: Ghent University)H-Index: 28
Last. Heleen Dewitte (UGent: Ghent University)H-Index: 18
view all 4 authors...
In less than one year since the outbreak of the COVID-19 pandemic, two mRNA-based vaccines, BNT162b2 and mRNA-1273, were granted the first historic authorization for emergency use, while another mRNA vaccine, CVnCoV, progressed to phase 3 clinical testing. The COVID-19 mRNA vaccines represent a new class of vaccine products, which consist of synthetic mRNA strands encoding the SARS-CoV-2 Spike glycoprotein, packaged in lipid nanoparticles to deliver mRNA to cells. This review digs deeper into th...
#1Kristie Bloom (University of the Witwatersrand)H-Index: 11
#2Fiona T. van den Berg (University of the Witwatersrand)H-Index: 4
Last. Patrick Arbuthnot (University of the Witwatersrand)H-Index: 33
view all 3 authors...
Vaccinology is shifting toward synthetic RNA platforms which allow for rapid, scalable, and cell-free manufacturing of prophylactic and therapeutic vaccines. The simple development pipeline is based on in vitro transcription of antigen-encoding sequences or immunotherapies as synthetic RNA transcripts, which are then formulated for delivery. This approach may enable a quicker response to emerging disease outbreaks, as is evident from the swift pursuit of RNA vaccine candidates for the global SAR...
#1Mark L. BraderH-Index: 14
#2Sean J. WilliamsH-Index: 1
Last. Lin JinH-Index: 7
view all 6 authors...
Abstract Understanding the structure of messenger RNA lipid nanoparticles (mRNA-LNP) and specifically the microenvironment of the mRNA molecules within these entities is fundamental to advancing their biomedical potential. Here we show that a permeating cationic dye, thionine, can serve as a cryogenic electron microscopy (cryo-EM) contrasting agent by binding selectively to encapsulated mRNA without disturbing LNP morphology. Cryo-EM images identify the mRNA location revealing that mRNA may exis...
#1Federica Sebastiani (Malm枚 University)H-Index: 9
#2Marianna Yanez Arteta (AstraZeneca)H-Index: 3
Last. Marit茅 C谩rdenas (Malm枚 University)H-Index: 26
view all 17 authors...
Emerging therapeutic treatments based on the production of proteins by delivering mRNA have become increasingly important in recent times. While lipid nanoparticles (LNPs) are approved vehicles for small interfering RNA delivery, there are still challenges to use this formulation for mRNA delivery. LNPs are typically a mixture of a cationic lipid, distearoylphosphatidylcholine (DSPC), cholesterol, and a PEG-lipid. The structural characterization of mRNA-containing LNPs (mRNA-LNPs) is crucial for...
Leaked documents show that some early commercial batches of Pfizer-BioNTech鈥檚 covid-19 vaccine had lower than expected levels of intact mRNA, prompting wider questions about how to assess this novel vaccine platform, writes Serena Tinari
#1Daan J.A. Crommelin (UU: Utrecht University)H-Index: 90
#2Thomas J. Anchordoquy (UM: University of Montana)H-Index: 38
Last. Enrico Mastrobattista (UU: Utrecht University)H-Index: 50
view all 5 authors...
As mRNA vaccines became the frontrunners in late-stage clinical trials to fight the COVID-19 pandemic, challenges surrounding their formulation and stability became readily apparent. In this commentary, we first describe company proposals, based on available public information, for the (frozen) storage of mRNA vaccine drug products across the vaccine supply chain. We then review the literature on the pharmaceutical stability of mRNA vaccine candidates, including attempts to improve their stabili...
#1Lindsey R. Baden (Brigham and Women's Hospital)H-Index: 75
#2Hana M. El Sahly (BCM: Baylor College of Medicine)H-Index: 21
Last. C. Buddy CreechH-Index: 29
view all 37 authors...
Abstract Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle鈥揺...
#1Michael D. Buschmann (GMU: George Mason University)H-Index: 3
#2Manuel J. Carrasco (GMU: George Mason University)H-Index: 2
Last. Drew Weissman (UPenn: University of Pennsylvania)H-Index: 50
view all 6 authors...
The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as adjuvants and in vaccine reactogenicity. We present an overview of mRNA delivery systems and then focus on the lipid nanoparticles used in the current SARS-CoV-2 vaccine clinical trials. The review concludes with an analysis of the determinants o...
#1Yuchen Fan (Genentech)H-Index: 14
#2Maria Marioli (Hoffmann-La Roche)H-Index: 1
Last. Kelly Zhang (Genentech)H-Index: 15
view all 3 authors...
Abstract Lipid nanoparticles, especially liposomes and lipid/nucleic acid complexed nanoparticles have shown great success in the pharmaceutical industry. Their success is attributed to stable drug loading, extended pharmacokinetics, reduced off-target side effects, and enhanced delivery efficiency to disease targets with formidable blood-brain or plasma membrane barriers. Therefore, they offer promising formulation options for drugs limited by low therapeutic indexes in traditional dosage forms...
#1Jeong Hwan Kim (OSU: Oregon State University)H-Index: 18
#2Yulia Eygeris (OSU: Oregon State University)H-Index: 5
Last. Gaurav Sahay (OSU: Oregon State University)H-Index: 32
view all 4 authors...
mRNA vaccines have evolved from being a mere curiosity to emerging as COVID-19 vaccine front-runners. Recent advancements in the field of RNA technology, vaccinology, and nanotechnology have generated interest in delivering safe and effective mRNA therapeutics. In this review, we discuss design and self-assembly of mRNA vaccines. Self-assembly, a spontaneous organization of individual molecules, allows for design of nanoparticles with customizable properties. We highlight the materials commonly ...
Cited By29
#1Edo Kon (TAU: Tel Aviv University)H-Index: 3
#2Uri Elia (Israel Institute for Biological Research)H-Index: 8
Last. Dan Peer (TAU: Tel Aviv University)H-Index: 54
view all 3 authors...
mRNA Lipid nanoparticles (LNPs) have recently been propelled onto the center stage of therapeutic platforms due to the success of the SARS-CoV-2 mRNA LNP vaccines (mRNA-1273 and BNT162b2), with billions of mRNA vaccine doses already shipped worldwide. While mRNA vaccines seem like an overnight success to some, they are in fact a result of decades of scientific research. The advantage of mRNA-LNP vaccines lies in the modularity of the platform and the rapid manufacturing capabilities. However, th...
#1Mingyuan Li (Tianjin University of Science and Technology)H-Index: 3
#2Yuan Li (Tianjin University of Science and Technology)H-Index: 2
view all 12 authors...
The current COVID-19 epidemic has greatly accelerated the application of mRNA technology to our real world, and during this battle mRNA has proven it's unique advantages compared to traditional biopharmaceutical and vaccine technology. In order to overcome mRNA instability in human physiological environments, mRNA chemical modifications and nano delivery systems are two key factors for their in聽vivo applications. In this review, we would like to summarize the challenges for clinical translation ...
Vaccination is the most effective means of preventing infectious diseases and saving lives. Modern biotechnology largely enabled vaccine development. In the meantime, recent advances in pharmaceutical technology have resulted in the emergence of nanoparticles that are extensively investigated as promising miniaturized drug delivery systems. Scientists are particularly interested in liposomes as an important carrier for vaccine development. Wide acceptability of liposomes lies in their flexibilit...
#1Jaemun KimH-Index: 1
#2Ji Yul KimH-Index: 1
Last. Eun Gyo LeeH-Index: 13
view all 7 authors...
Transient gene expression is a suitable tool for the production of biopharmaceutical candidates in the early stage of development and provides a simple and rapid alternative to the generation of stable cell line. In this study, an efficient transient gene expression methodology using DC-Chol/DOPE cationic liposomes and pDNA in Chinese hamster ovary suspension cells was established through screening of diverse lipoplex formation conditions. We modulated properties of both the liposome formation a...
#2Sangeun LeeH-Index: 8
Last. Claus-Michael LehrH-Index: 94
view all 6 authors...
Co-delivery of different species of protein-encoding polynucleotides, e.g., messenger RNA (mRNA) and plasmid DNA (pDNA), using the same nanocarrier is an interesting topic that remains scarcely researched in the field of nucleic acid delivery. The current study hence aims to explore the possibility of the simultaneous delivery of mRNA (mCherry) and pDNA (pAmCyan) using a single nanocarrier. The latter is based on gelatin type A, a biocompatible, and biodegradable biopolymer of broad pharmaceutic...
Last. Michal Otyepka (Technical University of Ostrava)H-Index: 73
view all 5 authors...
Recent advances in RNA-based medicine have provided new opportunities for the global current challenge, i.e., the COVID-19 pandemic. Novel vaccines are based on a messenger RNA (mRNA) motif with a lipid nanoparticle (LNP) vector, consisting of high content of unique pH-sensitive ionizable lipids (ILs). Here we provide molecular insights into the role of the ILs and lipid mixtures used in current mRNA vaccines. We observed that the lipid mixtures adopted a nonlamellar organization, with ILs separ...
Last. Ajit VikramH-Index: 23
view all 5 authors...
microRNAs (miRs) are emerging as attractive therapeutic targets because of their small size, specific targetability, and critical role in disease pathogenesis. However, <20 miR targeting molecules have entered clinical trials, and none progressed to phase III. The difficulties in miR target identification, the moderate efficacy of miR inhibitors, cell type-specific delivery, and adverse outcomes have impeded the development of miR therapeutics. These hurdles are rooted in the functional complexi...
#1Miora Rakotoarisoa (Universit茅 Paris-Saclay)H-Index: 3
#2Borislav Angelov (CAS: Academy of Sciences of the Czech Republic)H-Index: 34
Last. Angelina Angelova (Universit茅 Paris-Saclay)H-Index: 42
view all 7 authors...
Last. Sukathida UbolH-Index: 26
view all 10 authors...
The COVID-19 pandemic has currently created an unprecedented threat to human society and global health. A rapid mass vaccination to create herd immunity against SARS-CoV-2 is a crucial measure to ease the spread of this disease. Here, we investigated the immunogenicity of a SARS-CoV-2 subunit vaccine candidate, a SARS-CoV-2 spike glycoprotein encapsulated in N,N,N-trimethyl chitosan particles or S-TMC NPs. Upon intraperitoneal immunization, S-TMC NP-immunized mice elicited a stronger systemic an...
Lipid vesicles (liposomes) are a unique and fascinating type of polymolecular aggregates, obtained from bilayer-forming amphiphiles鈥攐r mixtures of amphiphiles鈥攊n an aqueous medium. Unilamellar vesicles consist of one single self-closed bilayer membrane, constituted by the amphiphiles and an internal volume which is trapped by this bilayer, whereby the vesicle often is spherical with a typical desired average diameter of either about 100 nm or tens of micrometers. Functionalization of the externa...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.